Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Australian Clinical Labs Ltd ( (AU:ACL) ) has shared an update.
Australian Clinical Labs Limited has announced a change in its substantial holding status as of March 3, 2025. The company, which operates within the healthcare sector, has seen a shift in the relevant interests and associations of its voting securities, indicating a potential impact on its shareholder structure and market positioning.
The most recent analyst rating on (AU:ACL) stock is a Buy with a A$3.60 price target. To see the full list of analyst forecasts on Australian Clinical Labs Ltd stock, see the AU:ACL Stock Forecast page.
More about Australian Clinical Labs Ltd
Average Trading Volume: 869,831
Technical Sentiment Signal: Sell
Current Market Cap: A$536.1M
For a thorough assessment of ACL stock, go to TipRanks’ Stock Analysis page.